A Review Article: Clean Water Contamination as a Risk Factor for Acanthamoeba Keratitis


Muhammad Duta Alfarisi Alfarisi
I Wayan Mustika Maha Putra
Karina Khilmi Adzuba
Luh Komang Diah Lakhsmi Paramita
Decky Aditya Zulkarnaen


Introduction: Infectious keratitis is one of the main causes of visual impairment. The incidence of acanthamoeba keratitis is relatively rare, while the prevalence is around 1 to 9 cases per 100.000. One of the factors supporting the occurrence of acanthamoeba keratitis is the increasing use of contact lenses around the world.

Content: When there is microtrauma to the cornea, it can cause the expression of the mannose on the surface. With the emergence of mannose in the form of glycoproteins, it will be a requirement for the attachment of Acanthamoeba spp.

Conclusion: Keratitis Acanthamoeba is an infectious disease of the cornea due to the use of contact lenses that are too long exposed to water which causes the entry of Acanthamoeba. This disease has a good prognosis with immediate drug administration within the first 3 weeks after the onset of symptoms.



1. Austin A, Lietman T, Rose-Nussbaumer J. Update on the Management of Infectious Keratitis. Ophthalmology. 2017;124(11):1678–89.
2. Gallagher D, McElnea E, Fahy G. Acanthamoeba Keratitis in the Absence of Predisposing Risk Factors. Arch Ophthalmol Optym. 2018;1(1):23–7.
3. Varacalli G, Di Zazzo A, Mori T, Dohlman TH, Spelta S, Coassin M, et al. Challenges in Acanthamoeba Keratitis: A review. J Clin Med. 2021;10(5):1–10.
4. Wei Z, Cao K, Wang L, Baudouin C, Labbé A, Liang Q. Corneal changes in acanthamoeba keratitis at various levels of severity: An In Vivo Confocal Microscopic Study. Transl Vis Sci Technol. 2021;10(7):1–12.
5. Scruggs BA, Quist TS, Zimmerman MB, Salinas JL, Greiner MA. Risk factors, management, and outcomes of Acanthamoeba keratitis: A retrospective analysis of 110 cases. Am J Ophthalmol Case Reports [Internet]. 2022;2–8. Available from: https://doi.org/10.1016/j.ajoc.2022.101372
6. Bouten M, Elsheikha H. Diagnosis and Management of Acanthamoeba Keratitis: A Continental Approach. Parasitologia. 2022;2(0):167–97.
7. Skryabina Y V, Astakhov YS, Konenkova YS, Varganova TS, Petukhov VP, Nokhrina K V, et al. Clinical care of acanthamoeba keratitis patients. Ophthalmol J. 2017;10(4):24–31.
8. Smith C, Ashraf N, Haghnegahdar M, Goins K, Newman JR. Acanthamoeba Keratitis: A Single-Institution Series of Four Cases With Literature Review. Cureus. 2022;14(1).
9. Shah IA, Shah SA, Rai P, Abbasi SA, Fatima H, Soomro AA. Etiology of Infectious Keratitis as Seen at a Tertiary Care Center in Larkana, Pakistan. Pakistan J Ophthalmol. 2016;32(1):48–52.
10. Christine RN. Corneal Ulcers with Bacterial Causes; A Case Report. Anthology of Science FK UKI. 2018;7:63–9.
11. Szentmáry N, Daas L, Shi L, Laurik KL, Lepper S, Milioti G, et al. Acanthamoeba keratitis – Clinical signs, differential diagnosis and treatment. J Curr Ophthalmol. 2019;31(1):16–23.
12. Riset Kesehatan Dasar. 2013. Laporan Hasil Riset Kesehatan Daerah Nasional. Badan penelitian dan pengembangan kesehatan. Jakarta.
13. Muslim F, Sitompul R, Edwar L. Acanthamoeba keratitis: A challenge in diagnosis and the role of amniotic membrane transplant as an alternative therapy. Med J Indones. 2018;27(4):299–303.
14. Lorenzo-Morales J, Khan NA, Walochnik J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasites. 2015;22(10):2–20.
15. Skryabina YV, Astakhov YS, Konenkova YS, Varganova TS, Petukhov VP, Nokhrina KV, et al. In Ophthalmology Practitioners. Ophthalmol J. 2019;12(1):60–71.
16. Thatte, Shreya, et al,. (2017). Efficacy of Amniotic Membrane Transplantation in Refractory Infective Keratitis Leading to Stromal Thinning, Descematocele and Perforations. JOJ Ophthalmology. 3. 10.19080/JOJO.2017.03.555611.
17. Fanselow N, Sirajuddin N, Yin XT, Huang AJW, Stuart PM. Acanthamoeba keratitis, Pathology, Diagnosis and Treatment. Pathogens. 2021;10(323):1–11.
18. Ting DSJ, Ho CS, Deshmukh R, Said DG, Dua HS. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Springer Nat [Internet]. 2021;35(4):1084–101. Available from: http://dx.doi.org/10.1038/s41433-020-01339-3